Post-Transplant Lymphoproliferative Disorder in Liver Transplant Recipients: Characteristics, Management and Outcome from a Single-Centre Experience with >1000 Liver Transplantations

Affiliations

Khalid Mumtaz: Wexner Medical Center, Gastroenterology, Hepatology and Nutrition Division, The Ohio State University, Columbus, Ohio, USA
Nabiha Faisal: Liver Transplant Program/Multi-Organ Transplant Program, University Health Network, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
Max Marquez: Liver Transplant Program/Multi-Organ Transplant Program, University Health Network, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
Alicia Healey: Liver Transplant Program/Multi-Organ Transplant Program, University Health Network, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
Leslie B Lilly: Liver Transplant Program/Multi-Organ Transplant Program, University Health Network, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
Eberhard L Renner: Liver Transplant Program/Multi-Organ Transplant Program, University Health Network, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada

Abstract

BACKGROUND: The literature regarding post-transplant lymphoproliferative disorder (PTLD) in liver transplant recipients (LTRs) is limited.

ISSN: 2291-2789 (Print); 2291-2797 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://onlinelibrary.wiley.com/journal/1720